CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 55 filers reported holding CASI PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $12,000 | -36.8% | 9,757 | -20.2% | 0.00% | – |
| Q2 2021 | $19,000 | -85.7% | 12,228 | -77.9% | 0.00% | – |
| Q1 2021 | $133,000 | +111.1% | 55,269 | +159.0% | 0.00% | – |
| Q4 2020 | $63,000 | +37.0% | 21,341 | -28.3% | 0.00% | – |
| Q3 2020 | $46,000 | -37.0% | 29,773 | +0.5% | 0.00% | – |
| Q2 2020 | $73,000 | +114.7% | 29,626 | +78.0% | 0.00% | – |
| Q1 2020 | $34,000 | -78.2% | 16,646 | -67.0% | 0.00% | – |
| Q4 2019 | $156,000 | +88.0% | 50,431 | +102.9% | 0.00% | – |
| Q3 2019 | $83,000 | -20.2% | 24,859 | -23.5% | 0.00% | – |
| Q2 2019 | $104,000 | +160.0% | 32,510 | +130.5% | 0.00% | – |
| Q1 2019 | $40,000 | -63.6% | 14,103 | -40.2% | 0.00% | – |
| Q3 2018 | $110,000 | +254.8% | 23,598 | +525.3% | 0.00% | – |
| Q2 2018 | $31,000 | -83.9% | 3,774 | -91.8% | 0.00% | – |
| Q1 2018 | $193,000 | -11.1% | 46,200 | -30.8% | 0.00% | – |
| Q4 2017 | $217,000 | – | 66,720 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IDG-Accel China Growth Fund III Associates L.P. | 7,973,536 | $19,136,000 | 25.80% |
| Consonance Capital Management LP | 10,540,715 | $25,298,000 | 2.70% |
| Wellington Shields & Co., LLC | 1,832,769 | $4,399,000 | 1.58% |
| Tri Locum Partners LP | 1,500,000 | $3,600,000 | 0.89% |
| Wellington Shields Capital Management, LLC | 2,231,765 | $5,356,000 | 0.51% |
| Ghost Tree Capital, LLC | 650,000 | $1,560,000 | 0.37% |
| 1492 Capital Management LLC | 159,486 | $382,000 | 0.11% |
| Ikarian Capital, LLC | 1,268,154 | $3,044,000 | 0.10% |
| Sio Capital Management, LLC | 203,432 | $488,000 | 0.10% |
| Aristides Capital LLC | 63,250 | $152,000 | 0.06% |